Main Characteristics of Macrolides and Azalides
The macrolide group stands out among other antibiotics due to its specific chemical structure—very bulky macrocyclic compounds.
In medical practice, these drugs are generally divided into classical and newer generations:
- Classical macrolides: the most prominent and historically significant representative is erythromycin.
- Newer generations (including azalides): this subgroup includes azithromycin and clarithromycin.
A key advantage of modern macrolides is their pharmacokinetics, which allows for infrequent dosing (just once or twice daily). These drugs possess a broad spectrum of activity. Their most important clinical feature is the ability to penetrate human host cells, making them effective weapons against intracellular pathogens such as Legionella and Haemophilus species.
Regarding their effect on the microbial cell, macrolides function primarily as bacteriostatic agents (inhibiting bacterial growth and reproduction). However, this effect is not strictly static: depending on the specific pathogen, the action can transform into bactericidal (complete eradication of the microbe).
Lincosamides: Similarities and Differences
Lincosamides are closely related to macrolides in terms of their clinical characteristics, although chemically they are entirely different substances.
The main representatives of this group are lincomycin and its chlorinated derivative, clindamycin. Like macrolides, lincosamides exert a bacteriostatic effect on bacteria. Their spectrum of antimicrobial activity largely overlaps with that of macrolides.
However, lincosamides have their own unique niche. Specifically, clindamycin is notable for its exceptionally high activity against anaerobic flora, making it indispensable in the treatment of specific infections that develop in oxygen-deprived environments.
Highly Toxic Agents: Chloramphenicol and Polypeptides
The medical armamentarium includes antibiotics whose use is strictly limited due to their pronounced damaging effects on the human body.
1. Chloramphenicol This broad-spectrum antibiotic effectively combats intracellular parasites with a bacteriostatic effect, much like macrolides. Its primary limitation lies in its chemical structure: the molecule contains a specific nitrobenzene core. This core is responsible for the high toxicity of chloramphenicol, as the drug damages not only bacterial structures but also healthy human cells.
2. Polypeptides (Polymyxins) Unlike macrolides, polymyxins possess a narrow spectrum of activity—they act exclusively against Gram-negative microflora with a bactericidal effect. Due to their extremely high systemic toxicity, parenteral administration is currently discontinued or severely restricted. Polymyxins are reserved exclusively for topical use.
Specific Groups: Rifamycins and Polyenes
Certain groups of antimicrobial agents are utilized for very narrow, specific clinical tasks.
Rifamycins (Representative: Rifampin) These are large molecules with complex structures. Unlike macrolides, rifampin acts as a bactericidal agent. It has a broad spectrum of activity and is also capable of targeting intracellular parasites. However, its main distinguishing feature is its extraordinary efficacy against mycobacteria. For this reason, rifampin is predominantly used today as part of combination therapy for tuberculosis.
Polyenes (Antifungal Antibiotics) This group, which includes amphotericin B and nystatin, is designed to combat fungal infections. Polyenes exhibit significant toxicity, dictating strict differentiation in their application:
- Nystatin is applied strictly topically to avoid systemic toxic effects.
- Amphotericin B, despite its risks, remains the drug of choice for severe systemic mycoses when saving a patient's life is paramount.